• A1M -0.63 %
  • buy 1.27
  • sell 1.28
  • latest 1.27

ROSgard™ – the first drug based on the protein A1M

Acute kidney injuries and pre-eclampsia affect millions of people each year and are conditions for which there is currently no curative treatment. With ROSgard™ it would be possible to give the body an extra boost of the protein A1M and thereby treat these conditions.

A1M Pharma AB | Scheelevägen 22 | 223 63 Lund
+46 46 286 50 30 | info@a1m.se
Member of Preeclampsia Foundation
Legal disclaimer | © Copyright - A1M